The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical significance of crown-like structures to trastuzumab response in patients with primary invasive HER2+ breast cancer.
 
Constantinos Savva
No Relationships to Disclose
 
Charles N Birts
No Relationships to Disclose
 
Stéphanie A Laversin
No Relationships to Disclose
 
Alicia Lefas
No Relationships to Disclose
 
Jamie Krishnan
No Relationships to Disclose
 
Aron Schapira
No Relationships to Disclose
 
Margaret Ashton-Key
No Relationships to Disclose
 
Max Crispin
No Relationships to Disclose
 
Peter W. M. Johnson
Honoraria - Bristol-Myers Squibb; Genmab; immunocore; Kymera; Novartis; Takeda
Consulting or Advisory Role - Epizyme; Janssen; Oncimmune
Research Funding - Epizyme (Inst)
Patents, Royalties, Other Intellectual Property - Combined use of Fc gamma RIIb (CD32b) and CD20 - specific antibodies. WO Patent, PCT/GB2011/051572; EU11760819.0
 
Jeremy P Blaydes
No Relationships to Disclose
 
Ellen Copson
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; NanoString Technologies; NanoString Technologies; Pfizer
Speakers' Bureau - AstraZeneca; AstraZeneca; Pfizer; Pfizer; Roche
Research Funding - SECA
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Ramsey I Cutress
Research Funding - Seca (Inst)
 
Stephen A Beers
Consulting or Advisory Role - Bioinvent; ImCheck therapeutics
Research Funding - Bioinvent
Patents, Royalties, Other Intellectual Property - Receive royalties for patents